Skip to content
1st Counsel – Lifestyle
Author:
Telix Pharmaceuticals Limited
TLX101-Px (Pixlumi®) MAA Accepted in Europe
April 30, 2026
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
April 29, 2026
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
April 27, 2026
←
Previous Page
1
2
3